| Typicality: | 0.351 |
| Saliency: | 0.238 |
| from cormatrix’s existing marketed products | 6 | other |
| in return | 3 | manner |
| from potential milestone payments | 3 | other |
| ligand → receive → revenue | 5 |
| ligand → receive → a portion of revenue | 3 |
| negative | neutral | positive |
| 0.006 | 0.815 | 0.178 |
| Raw frequency | 8 |
| Normalized frequency | 0.238 |
| Modifier score | 0.500 |
| Perplexity | 434.517 |